← Eichor
Condition: Celecoxib Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Celecoxib

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07494565INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder
Phase 3 · 3 location(s) · Universiteit Antwerpen · NCT05644301Effects and Mechanisms of Celecoxib on Intracerebral Hemorrhage
Phase 2 · 1 location(s) · National Taiwan University Hospital · NCT05434065Neoadjuvant Toripalimab With or Without Celecoxib in dMMR/MSI-H Colorectal Cancer
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT03926338Triple Negative Breast Cancer and Celecoxib. Pilot Study
Phase 2 · 1 location(s) · Université de Sherbrooke · NCT07104266Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
Phase 2 · 1 location(s) · Zhejiang University · NCT05731726Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal Cancer
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06903858Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer
Phase 2 · 4 location(s) · Emory University · NCT07174570Celecoxib in Parkinson Disease as Adjuvant Therapy
Phase 1/Phase 2 · 1 location(s) · Tanta University · NCT07246278Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest
Phase 2 · 1 location(s) · Mayo Clinic · NCT06997068Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT03498326A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cis
Phase 1/Phase 2 · 1 location(s) · Shanghai 6th People's Hospital · NCT07632235TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adj
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05343013Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis
Phase 3 · 1 location(s) · Yonsei University · NCT06545526Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome
NA · 1 location(s) · Air Force Military Medical University, China · NCT06722534Celecoxib for ENT Pain Management
Phase 2 · 1 location(s) · University of Wisconsin, Madison · NCT06505187Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute Exacerbation
Phase 3 · 1 location(s) · Laboratorios Silanes S.A. de C.V. · NCT06863636CELECOXIB Plasma and Cerebral Spinal Fluid Pharmacokinetics in Children
Phase 2 · 1 location(s) · Children's Hospital of Eastern Ontario · NCT0134420099Tc-MDP Treatment for Knee Osteoarthritis
NA · 1 location(s) · Xinhua Hospital, Shanghai Jiao Tong University School of Med · NCT02993029Clinical Study Evaluating Safety of Pentoxifylline and Celecoxib in Patients With Grand-Mal Epilepsy Treated by Phenytoi
Phase 2 · 1 location(s) · Mostafa Bahaa · NCT05637086
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.